Home › Bronchopulmonary Dysplasia › NCT07307612
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
Improving Lung Health in Premature Babies Through Early Nutrition: The More & Early Nutritional Delivery for Bronchopulmonary Dysplasia (MEND-BPD) Trial
Who can join
1 Day – 3 Days · All sexes
Full eligibility criteria
Inclusion Criteria: * Gestational age ≤ 28 weeks of gestation * Postnatal age \< 72 hours Exclusion Criteria: * Congenital malformations * Chromosomal anomalies * Terminal illness needing to limit or withhold support
About the study
This Phase II, parallel-group, masked, randomized clinical trial aims to evaluate whether a DHA/ARA-enriched, fortified human milk diet administered during the first 14 days of life reduces respiratory morbidity and improves lung function in extremely preterm (EPT) infants (born at ≤28 weeks gestation).
What is being tested
- High-energy group (dietary supplement)
- Standard-energy group (other)
Sponsor: University of Alabama at Birmingham · Participants: 150 · Started: Sep 21, 2026
Contact the study team
- Ariel A. Salas, MD, MSPH · Phone: 205-934-4680
Official record on ClinicalTrials.gov — NCT07307612
Locations in the U.S.
| Alabama | University of Alabama at Birmingham, Birmingham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.